Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06522880
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-09
Brief Title:
Cytomegalovirus CMV Transmission and Immune Tracking TransmIT Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Cytomegalovirus CMV Transmission and Immune Tracking TransmIT Study An Observational Study to Evaluate CMV Transmission and Immune Correlates of Viral Shedding Among Young Children in Early Education and Care Settings
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of STAGE I of the CMV TransmIT Study is to determine the prevalence of CMV shedding in children up to and including 36 months of age in large group childcare centers and in staff who regularly work at the center Participants will complete a health survey and provide one saliva sample for CMV PCR testing In addition infrastructure for the study will be developed eg community engagement to build the network of centers data pipelines digital platform sampling workflows and participant sample collection at home will be piloted These activities will inform the design of STAGE II
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None